CXCL13 and common variable immunodeficiency: The influx of B and T cell populations, together with the beneficial therapeutic effect of B cell depletion by Rituximab in CVID-related granulomata, may be a manifestation of an essential functional role of CXCL13 in the pathology of granulomata in CVID [71, 72].